Published • loading... • Updated
ESTEVE CDMO commences $15.5m expansion of US facility - Pharmafile
Summary by pharmafile.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
ESTEVE CDMO commences $15.5m expansion of US facility - Pharmafile
ESTEVE CDMO, a global Contract Development and Manufacturing Organization (CDMO) specialising in small molecule active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, announced it had commenced a $15.5m investment in the Chicago site, acquired in July 2025. The expansion of the Morton Grove, Illinois, facility will enhance production capabilities and associated space through reactor upgrades to add […] The post ESTEVE CDMO co…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
